Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation ofin vitrometabolism using cDNA-expressed human P450s and human liver microsomes
Authors:
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 26 (7) , 681-693
Abstract
1. We evaluated the specificity of 15 substrates and 14 inhibitors of the cytochrome P450s using nine human P450 forms expressed in HepG2 cells using a recombinant vaccinia virus and also in human liver microsomes. 2. Coumarin, 7-ethoxyresorufin, 7-benzyloxyresorufin, tolbutamide, aniline and diazepam were form-selective substrates towards CYP2A6, the CYP1A subfamily, CYP2B6, the CYP2C subfamily, CYP2E1 and the CYP3A subfamily respectively. However, a selective substrate for CYP2D6 was not found among the chemicals tested. 3. SKF-525A inhibited > 40% of the metabolic activity of all substrates tested, and the inhibitory effects differed among P450 forms. Sulphaphenazole, 7,8-benzoflavone, quinidine and troleandomycin were selective inhibitors of the CYP2C subfamily (except CYP2C19), the CYP1A subfamily, CYP2D6 and the CYP3A subfamily respectively. Methoxsalen (CYP2A6 inhibitor) inhibited the metabolic activity of CYP1A2 as well as that of CYP2A6. Diethyldithiocarbamate (CYP2E1 inhibitor) inhibited the metabolic activities of CYP2A6 and CYP2C19 in addition to that of CYP2E1. 4. Our results indicated that substrates and inhibitors reported as P450 selective probes are not necessarily specific for individual human P450 forms. These results may provide useful information regarding human P450 substrates and inhibitors in vitro using human liver microsomal samples.Keywords
This publication has 40 references indexed in Scilit:
- Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1Pharmacogenetics, 1995
- Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virusPharmacogenetics, 1995
- The importance of substrate concentration in determining cytochromes P450 therapeutically relevant in vivoPharmacogenetics, 1994
- Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoidsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Involvement of a Cytochrome P4502D Subfamily in Human Liver Microsomal Bunitrolol 4-Hydroxylation.Biological and Pharmaceutical Bulletin, 1994
- Hepatic microsomal tolbutamide hydroxylation in Japanese: in vitro evidence for rapid and slow metabolizersPharmacogenetics, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypePharmacogenetics, 1991
- Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomesBiochemical and Biophysical Research Communications, 1990
- Determination of diazepam and oxazepam using high-performance liquid chromatography and fourth-derivative spectrophotometric techniquesThe Analyst, 1988